Macquarie Group LTD Biomarin Pharmaceutical Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Macquarie Group LTD holds 120,615 shares of BMRN stock, worth $8.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

120,615

Previous 120,615 -0.0%

Holding current value

$8.04 Million

Previous $9.93 Million 14.62%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$74.43 - $92.22 $149,083 - $184,716	2,003 Added 1.69%	120,615 $9.93 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $888,191 - $1.15 Million	-11,653 Reduced 8.95%	118,612 $11.4 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $97,490 - $108,274	1,146 Added 0.89%	130,265 $11.5 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $20,803 - $24,072	-240 Reduced 0.19%	129,119 $11.2 Million
Q4 2022 Feb 21, 2023	BUY	$80.93 - $108.63 $32,291 - $43,343	399 Added 0.31%	129,359 $13.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $62,770 - $74,062	-764 Reduced 0.59%	128,960 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $1.72 Million - $2.09 Million	-24,040 Reduced 15.63%	129,724 $10.7 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $5.02 Million - $6.27 Million	-67,637 Reduced 30.55%	153,764 $11.9 Million
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $252,454 - $321,974	-3,520 Reduced 1.56%	221,401 $19.6 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $9,421 - $10,769	-126 Reduced 0.06%	224,921 $17.4 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $113,265 - $127,185	1,500 Added 0.67%	225,047 $18.8 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $1.16 Million - $1.41 Million	-15,524 Reduced 6.49%	223,547 $16.9 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $201,855 - $250,756	-2,780 Reduced 1.15%	239,071 $21 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $1.75 Million - $3.19 Million	24,322 Added 11.18%	241,851 $18.4 Million
Q2 2020 Aug 11, 2020	BUY	$79.55 - $124.22 $70,719 - $110,431	889 Added 0.41%	217,529 $26.8 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $349,713 - $474,565	-4,900 Reduced 2.21%	216,640 $18.3 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $118,256 - $158,920	-1,840 Reduced 0.82%	221,540 $18.7 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.65 Million - $1.93 Million	20,530 Added 10.12%	223,380 $19.1 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $487,518 - $571,009	5,790 Added 2.94%	202,850 $18 Million
Q4 2018 Feb 15, 2019	SELL	$80.14 - $106.07 $339,793 - $449,736	-4,240 Reduced 2.11%	197,060 $16.8 Million
Q3 2018 Nov 15, 2018	BUY	$93.92 - $105.72 $3.68 Million - $4.14 Million	39,170 Added 24.16%	201,300 $19.5 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $12.2 Million - $15.9 Million	160,430 Added 9437.06%	162,130 $15.3 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $271,845 - $324,205	-3,500 Reduced 67.31%	1,700 $138,000
Q4 2017 Feb 15, 2018	SELL	$80.76 - $95.13 $2.87 Million - $3.38 Million	-35,513 Reduced 87.23%	5,200 $379,000
Q3 2017 Nov 08, 2017	BUY	$80.6 - $94.95 $3.28 Million - $3.87 Million	40,713	40,713 $3.79 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Biomarin Pharmaceutical Inc Transaction History